Price
$1.07
Increased by 0.00%
Dollar volume (20D)
15.92 K
ADR%
10.86
Earnings report date
May 13, 2025
Shares float
3.40 M
Shares short
45.56 K [1.34%]
Shares outstanding
41.08 M
Market cap
47.25 M
Beta
-1.13
Price/earnings
N/A
20D range
0.94 1.30
50D range
0.90 2.19
200D range
0.80 3.08

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States.

Its lead product candidate is the selonabant, a small molecule antagonist of cannabinoid binding receptor type-1, which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity.

The company was incorporated in 2020 and is based in Lakeway, Texas.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Feb 11, 25 -0.09
Increased by +18.36%
-0.08
Decreased by -12.25%
Nov 12, 24 -0.08
Increased by +15.10%
-0.05
Decreased by -69.80%
Sep 25, 24 -0.05
Increased by +50.00%
-0.13
Increased by +61.54%
May 15, 24 -0.06
Increased by +45.45%
-0.12
Increased by +50.00%
Feb 13, 24 -0.11
Increased by +26.67%
-0.10
Decreased by -10.00%
Nov 14, 23 -0.10
Increased by +9.09%
-0.12
Increased by +16.67%
Sep 20, 23 -0.10
Increased by 0.00%
-0.11
Increased by +9.09%
May 11, 23 -0.11
Decreased by -37.50%
-0.16
Increased by +31.25%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Dec 31, 24 0.00
Decreased by N/A%
-2.46 M
Increased by +9.36%
Decreased by N/A%
Decreased by N/A%
Sep 30, 24 0.00
Decreased by N/A%
-2.20 M
Increased by +11.29%
Decreased by N/A%
Decreased by N/A%
Jun 30, 24 0.00
Decreased by N/A%
-1.35 M
Increased by +45.91%
Decreased by N/A%
Decreased by N/A%
Mar 31, 24 0.00
Decreased by N/A%
-1.65 M
Increased by +40.90%
Decreased by N/A%
Decreased by N/A%
Dec 31, 23 0.00
Decreased by N/A%
-2.72 M
Increased by +29.25%
Decreased by N/A%
Decreased by N/A%
Sep 30, 23 0.00
Decreased by N/A%
-2.48 M
Increased by +5.02%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-2.50 M
Decreased by -7.66%
Decreased by N/A%
Decreased by N/A%
Mar 31, 23 0.00
Decreased by N/A%
-2.80 M
Decreased by -49.36%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY